Polymorphous immunotherapy-induced cutaneous sarcoidosis
Lucy Mackie, Monica Terlizzo, Nicolo Battisti, Kara Heelan, Silvia Aguilar-Duran · 2026
Read Polymorphous immunotherapy-induced cutaneous sarcoidosis by Lucy Mackie, Monica Terlizzo, Nicolo Battisti, Kara Heelan, Silvia Aguilar-Duran (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13623434.txt.
Description
Lucy Mackie and colleagues published a 2026 case report of a patient developing a sarcoidosis-like reaction while on the immunotherapy drug pembrolizumab for breast cancer. Sarcoidosis is an inflammatory condition that forms immune-cell clusters in tissue, and this drug-driven copy appeared in two forms at once, a combination the authors say is unreported.
The patient, a sixty-eight-year-old woman treated for a triple-negative breast cancer, developed a plaque cluster on her nose resembling lupus pernio, a skin form of sarcoidosis, plus a forehead lump. Tender nodules up to four centimetres wide appeared on her forearms and knees, though she felt well. Scans showed swollen chest glands and inflamed lungs, and a skin biopsy confirmed the tell-tale cell clusters without infection. Blood tests backed the picture, and tuberculosis testing was negative. The team links the eruption to the immune treatment continued after her chemotherapy ended.
Catalog record
| CREATOR | Lucy Mackie, Monica Terlizzo, Nicolo Battisti, Kara Heelan, Silvia Aguilar-Duran |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5116 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |